Efficacy and safety of anti-interleukin-6 treatment in familial Mediterranean fever: a systematic literature review

Introduction Biological treatments are indicated in familial Mediterranean fever (FMF) patients with colchicine resistance or intolerance. Interleukin-1 (IL-1) inhibitors may not yield sufficient efficacy and safety. Interleukin-6 inhibitors (tocilizumab – TCZ) have been suggested to be potentially...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Saidane Olfa, Selma Bouden, Ameni Jerbi, Leila Rouached, Ines Mahmoud, Rawdha Tekaya, Aicha Ben Tekaya, Leila Abdelmoula
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Termedia Publishing House 2025-11-01
coleção:	Rheumatology
Assuntos:	anti-il-6 colchicine resistance familial mediterranean fever fmf tocilizumab
Acesso em linha:	https://reu.termedia.pl/Efficacy-and-safety-of-anti-interleukin-6-treatment-in-familial-Mediterranean-fever,199741,0,2.html
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!